Long acting relaxin
N/A
Report date: 2022/06/17 16:22:45
Base Information
Drug NameLong acting relaxin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAmbrx IncBristol-Myers Squibb Company
China Registration ClassN/A
Develop Information
Active CompaniesBristol-Myers Squibb CompanyAmbrx Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A